Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
ACHV compared with ALLO: revenue, margins and what each company keeps, and the suppliers and customers both name
ACHV
Achieve Life Sciences, Inc.
Change
Mkt cap
Revenue
Revenue
ALLO
Allogene Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
ACHV
Achieve Life Sciences, Inc.
vs
ALLO
Allogene Therapeutics, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
ACHV
Achieve Life Sciences, Inc.
Change
6.98
▲
+3.68%
· post 7.00
Mkt cap
$718.3M
Revenue
—
ALLO
Allogene Therapeutics, Inc.
Change
1.19
▲
+6.25%
· post 1.19
Closed
Nov 4 '26
Mkt cap
$386.9M
Revenue
$5M
Q2 FY26
vs
Compare
Closed
Nov 4 '26
ACHV
Achieve Life Sciences, Inc.
vs
ALLO
Allogene Therapeutics, Inc.
6.98
▲
+3.68%
post 7.00
Price
1.19
▲
+6.25%
post 1.19
$718.3M
Mkt cap
$386.9M
—
Revenue
$5M
Q2 FY26
Change
Change
ACHV
6.98
▲
+3.68%
vs
ALLO
1.19
▲
+6.25%
Closed
Nov 4 '26
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
Supply-chain overlap
Revenue flow
ACHV: latest quarter not drawable. ALLO: latest quarter is a loss; flow not drawable.
Method
›
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only ACHV
4
—
Sopharma, AD
unlisted
supplier
—
University of Bristol
unlisted
supplier
—
Adare Pharma Solutions
unlisted
supplier
—
Kristen Slaoui
unlisted
supplier
Shared
0
No shared counterparties.
Only ALLO
12
PFE
Pfizer
supplier
NTRA
Natera
supplier
CLLS
Cellectis
supplier
—
Arbor Biotechnologies
unlisted
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
supplier
8 more · ALLO chain
›
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
ACHV, solid
ALLO, dashed